USD 97.13
(-1.89%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 231.44 Million USD | 14.67% |
2022 | 181.15 Million USD | 12.89% |
2021 | 153.45 Million USD | 289.78% |
2020 | 102.7 Million USD | 14.47% |
2019 | 121 Million USD | -36.1% |
2018 | 129.42 Million USD | 33.74% |
2017 | 97.29 Million USD | 30.31% |
2016 | 78.65 Million USD | -9.88% |
2015 | 74.85 Million USD | -5.92% |
2014 | 76.33 Million USD | 28.4% |
2013 | 60.42 Million USD | 3.93% |
2012 | 50.75 Million USD | -21.67% |
2011 | 52.93 Million USD | 53.06% |
2010 | 32.24 Million USD | -22.54% |
2009 | 45.39 Million USD | -19.7% |
2008 | 42.1 Million USD | 27.57% |
2007 | 32.41 Million USD | 18.64% |
2006 | 19.01 Million USD | -7.12% |
2005 | 23.52 Million USD | -7.75% |
2004 | 27.34 Million USD | 9.98% |
2003 | 30.36 Million USD | 36.21% |
2002 | 21.15 Million USD | 54.34% |
2001 | 14.5 Million USD | 67.61% |
2000 | 7.77 Million USD | -15.62% |
1999 | 9.7 Million USD | 18.29% |
1998 | 8.1 Million USD | 51.85% |
1997 | 5.4 Million USD | -20.59% |
1996 | 6.8 Million USD | 61.9% |
1995 | 4.2 Million USD | 20.0% |
1994 | 3.6 Million USD | -10.26% |
1993 | 4 Million USD | 39.29% |
1992 | 2.8 Million USD | 47.37% |
1991 | 2 Million USD | 566.67% |
1990 | 300 Thousand USD | 200.0% |
1989 | -300 Thousand USD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q3 | 73.54 Million USD | -9.18% |
2024 Q2 | 72.5 Million USD | 16.38% |
2024 Q1 | 68.99 Million USD | 10.02% |
2023 Q2 | 56.54 Million USD | 10.38% |
2023 Q3 | 62.35 Million USD | 10.27% |
2023 Q4 | 59.06 Million USD | -5.28% |
2023 FY | - USD | 14.67% |
2023 Q1 | 51.23 Million USD | -8.25% |
2022 Q4 | 55.83 Million USD | 28.49% |
2022 Q3 | 43.45 Million USD | -17.82% |
2022 Q2 | 52.88 Million USD | 24.44% |
2022 FY | - USD | 12.89% |
2022 Q1 | 42.49 Million USD | -22.5% |
2021 Q2 | 14.33 Million USD | -2.01% |
2021 Q3 | 16.52 Million USD | 15.25% |
2021 Q4 | 54.83 Million USD | 231.81% |
2021 FY | - USD | 289.78% |
2021 Q1 | 14.63 Million USD | -4.18% |
2020 Q1 | 9.89 Million USD | -24.87% |
2020 Q3 | 16.24 Million USD | 473.31% |
2020 Q4 | 15.27 Million USD | -5.97% |
2020 FY | - USD | 14.47% |
2020 Q2 | 2.83 Million USD | -71.37% |
2019 Q2 | 15.56 Million USD | 49.55% |
2019 Q3 | 819 Thousand USD | -94.74% |
2019 Q4 | 13.17 Million USD | 1508.06% |
2019 FY | - USD | -36.1% |
2019 Q1 | 10.41 Million USD | -28.27% |
2018 FY | - USD | 33.74% |
2018 Q2 | 15.38 Million USD | 74.91% |
2018 Q4 | 14.51 Million USD | -33.38% |
2018 Q1 | 8.79 Million USD | -33.9% |
2018 Q3 | 21.78 Million USD | 41.58% |
2017 Q3 | 12.24 Million USD | -10.48% |
2017 FY | - USD | 30.31% |
2017 Q4 | 13.3 Million USD | 8.7% |
2017 Q2 | 13.67 Million USD | 128.23% |
2017 Q1 | 5.99 Million USD | -51.37% |
2016 Q4 | 12.32 Million USD | 282.35% |
2016 Q1 | 7.45 Million USD | -5.62% |
2016 Q2 | 11.72 Million USD | 57.16% |
2016 Q3 | 3.22 Million USD | -72.5% |
2016 FY | - USD | -9.88% |
2015 FY | - USD | -5.92% |
2015 Q2 | 12.35 Million USD | 34.92% |
2015 Q4 | 7.9 Million USD | -13.08% |
2015 Q1 | 9.15 Million USD | -36.37% |
2015 Q3 | 9.09 Million USD | -26.43% |
2014 Q4 | 14.39 Million USD | 14.34% |
2014 Q3 | 12.59 Million USD | 69.33% |
2014 Q2 | 7.43 Million USD | 14.53% |
2014 FY | - USD | 28.4% |
2014 Q1 | 6.49 Million USD | -40.49% |
2013 Q2 | 6.84 Million USD | 291.03% |
2013 FY | - USD | 3.93% |
2013 Q4 | 10.91 Million USD | -11.57% |
2013 Q1 | 1.75 Million USD | -16.7% |
2013 Q3 | 12.33 Million USD | 80.18% |
2012 Q3 | 9.41 Million USD | -8.54% |
2012 Q4 | 2.1 Million USD | -77.67% |
2012 Q2 | 10.29 Million USD | 25.07% |
2012 Q1 | 8.23 Million USD | -36.92% |
2012 FY | - USD | -21.67% |
2011 Q1 | 10.21 Million USD | 3.98% |
2011 Q3 | 9.98 Million USD | -8.1% |
2011 FY | - USD | 53.06% |
2011 Q2 | 10.86 Million USD | 6.36% |
2011 Q4 | 13.04 Million USD | 30.72% |
2010 FY | - USD | -22.54% |
2010 Q2 | 8.72 Million USD | 37.0% |
2010 Q3 | 4.9 Million USD | -43.75% |
2010 Q4 | 9.82 Million USD | 100.06% |
2010 Q1 | 6.37 Million USD | -42.05% |
2009 Q4 | 10.99 Million USD | 29.24% |
2009 FY | - USD | -19.7% |
2009 Q1 | 10.52 Million USD | -2.26% |
2009 Q2 | 8.96 Million USD | -14.82% |
2009 Q3 | 8.5 Million USD | -5.16% |
2008 Q2 | 11.54 Million USD | 26.24% |
2008 Q3 | 9.66 Million USD | -16.33% |
2008 Q4 | 10.77 Million USD | 11.5% |
2008 FY | - USD | 27.57% |
2008 Q1 | 9.14 Million USD | -2.9% |
2007 Q2 | 7.73 Million USD | 15.66% |
2007 Q4 | 9.42 Million USD | 12.14% |
2007 FY | - USD | 18.64% |
2007 Q1 | 6.68 Million USD | -2.66% |
2007 Q3 | 8.4 Million USD | 8.63% |
2006 Q1 | 5.68 Million USD | -19.11% |
2006 Q2 | 7.72 Million USD | 36.07% |
2006 Q3 | 7.15 Million USD | -7.48% |
2006 Q4 | 6.86 Million USD | -3.94% |
2006 FY | - USD | -7.12% |
2005 Q4 | 7.02 Million USD | 9.41% |
2005 Q3 | 6.41 Million USD | -23.86% |
2005 Q2 | 8.42 Million USD | 14.11% |
2005 Q1 | 7.38 Million USD | -2.85% |
2005 FY | - USD | -7.75% |
2004 Q2 | 9.08 Million USD | 19.61% |
2004 Q3 | 7.31 Million USD | -19.53% |
2004 Q4 | 7.6 Million USD | 4.01% |
2004 FY | - USD | 9.98% |
2004 Q1 | 7.59 Million USD | -10.1% |
2003 Q1 | 6.04 Million USD | -7.98% |
2003 FY | - USD | 36.21% |
2003 Q2 | 7.42 Million USD | 38.6% |
2003 Q4 | 8.21 Million USD | 5.0% |
2003 Q3 | 8.17 Million USD | 12.21% |
2002 Q4 | 5.68 Million USD | -1.75% |
2002 Q1 | 4.55 Million USD | 39.35% |
2002 Q2 | 5.18 Million USD | 12.94% |
2002 Q3 | 5.73 Million USD | 9.78% |
2002 FY | - USD | 54.34% |
2001 Q3 | 3.86 Million USD | 42.18% |
2001 Q4 | 4.19 Million USD | -17.15% |
2001 Q2 | 3.27 Million USD | -22.58% |
2001 FY | - USD | 67.61% |
2001 Q1 | 3.19 Million USD | 599.84% |
2000 Q3 | 2.3 Million USD | 29.6% |
2000 Q1 | 1.33 Million USD | -38.15% |
2000 Q2 | 1.7 Million USD | 23.37% |
2000 Q4 | 2.15 Million USD | -82.51% |
2000 FY | - USD | -15.62% |
1999 Q3 | 2.5 Million USD | 12.0% |
1999 Q1 | 1.9 Million USD | 40.0% |
1999 Q4 | 3 Million USD | 7.14% |
1999 Q2 | 2.3 Million USD | 19.05% |
1999 FY | - USD | 18.29% |
1998 Q3 | 2.2 Million USD | 9.09% |
1998 Q2 | 2 Million USD | 10.0% |
1998 Q1 | 1.8 Million USD | 17.65% |
1998 Q4 | 2 Million USD | -37.5% |
1998 FY | - USD | 51.85% |
1997 FY | - USD | -20.59% |
1997 Q1 | 1.1 Million USD | -13.33% |
1997 Q4 | 1.7 Million USD | 21.43% |
1997 Q3 | 1.2 Million USD | -17.65% |
1997 Q2 | 1.5 Million USD | 30.77% |
1996 Q2 | 1.7 Million USD | 0.0% |
1996 FY | - USD | 61.9% |
1996 Q3 | 2 Million USD | 10.53% |
1996 Q4 | 1.5 Million USD | -28.57% |
1996 Q1 | 1.7 Million USD | 90.0% |
1995 FY | - USD | 20.0% |
1995 Q4 | 1 Million USD | -44.44% |
1995 Q3 | 1.6 Million USD | 63.64% |
1995 Q2 | 1 Million USD | 37.5% |
1995 Q1 | 800 Thousand USD | 166.67% |
1994 Q4 | 300 Thousand USD | -62.5% |
1994 FY | - USD | -10.26% |
1994 Q1 | 1.3 Million USD | 8.33% |
1994 Q2 | 1.2 Million USD | -7.69% |
1994 Q3 | 800 Thousand USD | -33.33% |
1993 Q2 | 900 Thousand USD | -18.18% |
1993 FY | - USD | 39.29% |
1993 Q1 | 1.1 Million USD | 37.5% |
1993 Q4 | 1.2 Million USD | 50.0% |
1993 Q3 | 800 Thousand USD | -11.11% |
1992 Q2 | 900 Thousand USD | 200.0% |
1992 Q1 | 300 Thousand USD | -62.5% |
1992 Q3 | 700 Thousand USD | -22.22% |
1992 FY | - USD | 47.37% |
1992 Q4 | 800 Thousand USD | 14.29% |
1991 FY | - USD | 850.0% |
1991 Q1 | 2 Million USD | 176.92% |
1991 Q3 | 400 Thousand USD | -82.61% |
1991 Q4 | 800 Thousand USD | 100.0% |
1991 Q2 | 2.3 Million USD | 15.0% |
1990 Q1 | 600 Thousand USD | 140.0% |
1990 Q3 | 1.2 Million USD | 33.33% |
1990 Q4 | -2.6 Million USD | -316.67% |
1990 FY | - USD | 166.67% |
1990 Q2 | 900 Thousand USD | 50.0% |
1989 FY | - USD | 0.0% |
1989 Q4 | -1.5 Million USD | -475.0% |
1989 Q3 | 400 Thousand USD | 0.0% |
1989 Q1 | 400 Thousand USD | 0.0% |
1989 Q2 | 400 Thousand USD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Akoya Biosciences, Inc. | -45.63 Million USD | 607.192% |
AngioDynamics, Inc. | -14.29 Million USD | 1719.381% |
AtriCure, Inc. | -8.1 Million USD | 2954.137% |
Avinger, Inc. | -16.34 Million USD | 1515.894% |
Azenta, Inc. | 55.15 Million USD | -319.652% |
BioLife Solutions, Inc. | -45.23 Million USD | 611.61% |
The Cooper Companies, Inc. | 882.8 Million USD | 73.783% |
Daxor Corporation | 329.74 Thousand USD | -70089.24% |
Ekso Bionics Holdings, Inc. | -13.19 Million USD | 1853.614% |
Femasys Inc. | -13.16 Million USD | 1857.421% |
GlucoTrack, Inc. | -7.09 Million USD | 3363.884% |
Harvard Bioscience, Inc. | 9.49 Million USD | -2338.028% |
Hologic, Inc. | 1.29 Billion USD | 82.145% |
ICU Medical, Inc. | 307.69 Million USD | 24.782% |
Intuitive Surgical, Inc. | 2.39 Billion USD | 90.333% |
KORU Medical Systems, Inc. | -9.39 Million USD | 2562.257% |
LeMaitre Vascular, Inc. | 48.99 Million USD | -372.427% |
Innovative Eyewear, Inc. | -6.57 Million USD | 3619.958% |
Innovative Eyewear, Inc. | -6.57 Million USD | 3619.958% |
Masimo Corporation | 236.7 Million USD | 2.221% |
Microbot Medical Inc. | -10.63 Million USD | 2276.434% |
Meihua International Medical Technologies Co., Ltd. | 15.77 Million USD | -1367.558% |
Nephros, Inc. | -1.37 Million USD | 16883.321% |
NovoCure Limited | -175.86 Million USD | 231.602% |
NEXGEL, Inc. | -2.73 Million USD | 8577.729% |
NEXGEL, Inc. | -2.73 Million USD | 8577.729% |
Singular Genomics Systems, Inc. | -86.49 Million USD | 367.575% |
OraSure Technologies, Inc. | 76.15 Million USD | -203.897% |
Pro-Dex, Inc. | 8.33 Million USD | -2677.415% |
Pulse Biosciences, Inc. | -42.36 Million USD | 646.279% |
Predictive Oncology Inc. | -13.18 Million USD | 1855.741% |
Precision Optics Corporation, Inc. | -2.51 Million USD | 9313.635% |
QuidelOrtho Corporation | 545.6 Million USD | 57.58% |
Repligen Corporation | 124.29 Million USD | -86.208% |
Sanara MedTech Inc. | -289.09 Thousand USD | 80156.867% |
STAAR Surgical Company | 33.22 Million USD | -596.674% |
Sharps Technology, Inc. | -8.98 Million USD | 2677.193% |
Utah Medical Products, Inc. | 24.8 Million USD | -833.046% |
DENTSPLY SIRONA Inc. | 232 Million USD | 0.241% |
Jin Medical International Ltd. | 3.44 Million USD | -6622.327% |